Trial on endovascular treatment of unruptured aneurysms (TEAM): study monitoring and rationale for trial interruption or continuation

Journal of Neuroradiology

Volumn 34, Issue 1, 2007, Pages 33-41

  Raymond, J ^a   Meder, J F ^b   Molyneux, A J ^c   Fox, A J ^d   Johnston, S C ^e   Collet, J P ^f   Rouleau, I ^g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Aneurysms; Clinical trial; Intracranial; Therapy; Trial monitoring

Indexed keywords

ANEURYSM; CONSERVATIVE TREATMENT; ENDOVASCULAR SURGERY; FOLLOW UP; HUMAN; INTRACRANIAL ANEURYSM; MEDICAL RESEARCH; PATIENT COMPLIANCE; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ARTIFICIAL EMBOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL;

EMBOLIZATION, THERAPEUTIC; HUMANS; INTRACRANIAL ANEURYSM; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 34247281447     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurad.2007.01.011     Document Type: Review

References (11)

1. Chow S.C., and Liu J.P. Censored data and interim analysis. Design and analysis of clinical trials: concepts and methodologies (Wiley series in probability and statistics). Wiley-Interscience, 2nd (2003), John Wiley and Sons, Inc., New York
2. Gifford F. Bioethics. Community-equipoise and the ethics of randomized clinical trials 9 2 (1995) 127-148
3. Neurath O. Protokollsaetze in Erkenntnis 3 (1932): 204-214. This essay is translated by George Schick; see "Protocol Sentences" in Logical Positivism, ed. A. J. Ayer (New York: Free Press,1959): 199-208, esp. 201.
4. Pallay A. On the timing of a futility analysis in clinical trials. J. Biopharm. Stat. 10 (2000) 399-405
5. Raymond J., Guilbert F., Georganos S., Juravsky L., Lambert A., Lamoureux J., et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 34 (2003) 421-427
6. Raymond J., Meder J.F., Molyneux A.J., Fox A.J., Johnston S.C., Collet J.P., et al., The Trial On Endovascular Aneurysm Management Team Collaborative Group. Unruptured intracranial aneurysms: the unreliability of clinical judgment, the necessity for evidence, and reasons to participate in a randomized trial. J. Neuroradiol. 33 (2006) 211-219
7. Raymond J., Meder J.F., Molyneux A.J., Johnston S.C., Collet J.P., Rouleau I., and the Trial on Endovascular Aneurysm Management (TEAM) collaborative group. Unruptured intracranial aneurysms: the unreliability of clinical judgment, the necessity for evidence, and reasons to participate in a randomized trial. J. Neuroradiol. 33 4 (2006) 211-219
8. Schoenfeld D.A. Pro/con clinical debate: it is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Pro: futility stopping can speed up the development of effective treatments. Crit. Care 9 (2005) 34-36 (discussion 34-36)
9. Slutsky A.S., and Lavery J.V. Data Safety and Monitoring Boards. N. Engl. J. Med. 350 11 (2004) 1143-1147
10. Ware J.H., Muller J.E., and Braunwald E. The futility index. An approach to the cost-effective termination of randomized clinical trials. Am. J. Med. 78 (1985) 635-643
11. Wiebers D.O., and International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362 9378 (2003) 103-110